China Universal Asset Management Company’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Other funds holding SUPN
HWAM
WCM
CNAM
ETC
YIH
SOADOR
LSERS
PCM
China Universal Asset Management Company's SUPN Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Supernus Pharmaceuticals (SUPN) stake by 9.2% in Q2 2026, selling an estimated $45K and leaving 9,237 shares worth $430K. The position accounts for 0.03% of the portfolio, ranked #278.
China Universal Asset Management Company first reported a position in SUPN in Q3 2022 and has held it in 16 quarters since. The position peaked at $718K in Q4 2024. 64 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- China Universal Asset Management Company held 9,237 shares of Supernus Pharmaceuticals worth $430K as of Q2 2026.
- China Universal Asset Management Company sold 938 Supernus Pharmaceuticals shares in Q2 2026, an estimated $45K.
- Supernus Pharmaceuticals made up 0.03% of China Universal Asset Management Company's portfolio in Q2 2026, its #278 holding.
- China Universal Asset Management Company first reported a position in Supernus Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Supernus Pharmaceuticals position peaked at $718K in Q4 2024.
- 64 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.